🎉 M&A multiples are live!
Check it out!

Medincell Valuation Multiples

Discover revenue and EBITDA valuation multiples for Medincell and similar public comparables like Vivoryon Therapeutics, Pharming, and Galapagos.

Medincell Overview

About Medincell

Medincell SA is a technology-based pharmaceutical firm, aims to optimise the efficiency of medical treatments and make them accessible geographically. The company's product portfolio uses BEPO-patented technology to develop controlled, long-acting injectable medical treatments for a number of therapeutic fields. The firm has a single operating segment: ongoing research and development on processes that use biodegradable polymers to enable the controlled and prolonged release of the active principles of drugs into the human body and animals by means of injection.


Founded

2003

HQ

France
Employees

143

Website

medincell.com

Financials

LTM Revenue $20.7M

LTM EBITDA -$6.8M

EV

$503M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Medincell Financials

Medincell has a last 12-month revenue of $20.7M and a last 12-month EBITDA of -$6.8M.

In the most recent fiscal year, Medincell achieved revenue of $9.8M and an EBITDA of -$20.0M.

Medincell expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Medincell valuation multiples based on analyst estimates

Medincell P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $10.7M $9.8M XXX XXX XXX
Gross Profit $4.4M n/a XXX XXX XXX
Gross Margin 41% NaN% XXX XXX XXX
EBITDA -$28.4M -$20.0M XXX XXX XXX
EBITDA Margin -266% -203% XXX XXX XXX
Net Profit -$26.6M -$34.4M XXX XXX XXX
Net Margin -249% -349% XXX XXX XXX
Net Debt $20.8M $51.6M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Medincell Stock Performance

As of April 15, 2025, Medincell's stock price is EUR 14 (or $15).

Medincell has current market cap of EUR 447M (or $481M), and EV of EUR 468M (or $503M).

See Medincell trading valuation data

Medincell Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$503M $481M XXX XXX XXX XXX $-0.90

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Medincell Valuation Multiples

As of April 15, 2025, Medincell has market cap of $481M and EV of $503M.

Medincell's trades at 24.2x LTM EV/Revenue multiple, and -74.4x LTM EBITDA.

Analysts estimate Medincell's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Medincell and 10K+ public comps

Medincell Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $503M XXX XXX XXX
EV/Revenue 29.0x XXX XXX XXX
EV/EBITDA -47.9x XXX XXX XXX
P/E -19.2x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -67.9x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Medincell Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Medincell Valuation Multiples

Medincell's NTM/LTM revenue growth is 110%

Medincell's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.2M for the same period.

Over next 12 months, Medincell's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Medincell's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Medincell and other 10K+ public comps

Medincell Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -8% XXX XXX XXX XXX
EBITDA Margin -61% XXX XXX XXX XXX
EBITDA Growth -30% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 50% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue 6% XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 230% XXX XXX XXX XXX
Opex to Revenue 329% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Medincell Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics and Drug Delivery Systems comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Medincell M&A and Investment Activity

Medincell acquired  XXX companies to date.

Last acquisition by Medincell was  XXXXXXXX, XXXXX XXXXX XXXXXX . Medincell acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Medincell

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Medincell

When was Medincell founded? Medincell was founded in 2003.
Where is Medincell headquartered? Medincell is headquartered in France.
How many employees does Medincell have? As of today, Medincell has 143 employees.
Is Medincell publicy listed? Yes, Medincell is a public company listed on PAR.
What is the stock symbol of Medincell? Medincell trades under MEDCL ticker.
When did Medincell go public? Medincell went public in 2018.
Who are competitors of Medincell? Similar companies to Medincell include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Medincell? Medincell's current market cap is $481M
What is the current revenue of Medincell? Medincell's last 12-month revenue is $20.7M.
What is the current EBITDA of Medincell? Medincell's last 12-month EBITDA is -$6.8M.
What is the current EV/Revenue multiple of Medincell? Current revenue multiple of Medincell is 24.2x.
What is the current EV/EBITDA multiple of Medincell? Current EBITDA multiple of Medincell is -74.4x.
What is the current revenue growth of Medincell? Medincell revenue growth between 2023 and 2024 was -8%.
Is Medincell profitable? Yes, Medincell is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.